{"id":"W2765735024","doi":"10.2174/1874312901711010123","title":"Dose Escalation and Co-therapy Intensification Between Etanercept, Adalimumab, and Infliximab: The CADURA Study","year":2017,"lang":"en","type":"article","venue":"The Open Rheumatology Journal","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Clinical Research Institute; Credit Valley Hospital; Amgen (Canada); Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke; Southlake Regional Health Center","funders":"Amgen","keywords":"Medicine; Adalimumab; Infliximab; Etanercept; Internal medicine; Rheumatoid arthritis; De-escalation; Retrospective cohort study; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003729434,0.0004586116,0.000735137,0.0005209677,0.0003626444,0.0009088378,0.0007860018,0.0005736322,0.001239697],"category_scores_gemma":[0.01040096,0.0003470716,0.001390265,0.001062318,0.0004375815,0.0004769407,0.000543984,0.0009628159,0.0001593851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004619025,"about_ca_system_score_gemma":0.003788887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.09974147,"about_ca_topic_score_gemma":0.1241883,"domain_scores_codex":[0.9968302,0.001797334,0.0001773632,0.0003625403,0.0004840631,0.0003484394],"domain_scores_gemma":[0.991771,0.002598769,0.003344313,0.0005179269,0.0005790481,0.001188911],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.03514295,0.001902962,0.9446875,0.0002034402,0.002510667,0.00007902723,0.000303782,0.0003171849,0.000180742,0.00008080176,0.0005741059,0.01401681],"study_design_scores_gemma":[0.005584503,0.00666236,0.9841478,0.00008257398,0.001336037,0.0001211873,0.0002047946,0.0006874905,0.00008251172,0.00002861597,0.001043489,0.00001866422],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974745,0.001538432,0.00003581963,0.0001033501,0.000009384099,0.00008338121,0.000315956,0.000002944514,0.0004363088],"genre_scores_gemma":[0.9981439,0.0004907997,0.000243833,0.0001590492,0.00004524726,0.00007670518,0.0005613469,0.000002478394,0.0002766253],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09974147,"threshold_uncertainty_score":0.1983218,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08422064680375173,"score_gpt":0.399561123297553,"score_spread":0.3153404764938013,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}